Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
3.210
-0.105 (-3.17%)
May 14, 2025, 10:30 AM - Market open
Pulmonx Employees
Pulmonx had 291 employees as of December 31, 2024. The number of employees increased by 12 or 4.30% compared to the previous year.
Employees
291
Change (1Y)
12
Growth (1Y)
4.30%
Revenue / Employee
$300,595
Profits / Employee
-$196,196
Market Cap
129.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LUNG News
- 12 days ago - Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference - GlobeNewsWire
- 13 days ago - Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Pulmonx Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - EDAP Appoints Glen French to Board of Directors - GlobeNewsWire
- 2 months ago - Top 3 Health Care Stocks You May Want To Dump In February - Benzinga
- 2 months ago - Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day - GlobeNewsWire